FDA Approved: MESNA — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for MESNA submitted by Baxter Healthcare Company. The action updates MESNA's labeling under the NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Cystitis

Drugs mentioned

• MESNA (MESNA)

Snippet

SUPPL AP for MESNA (MESNA)